EPIC Program Annual Report 2009-2010 Appendix: Table IX
| Rank by Payment | Drug and Strength | Drug Type** | Number of Claims | EPIC Payments | Rank by Number of Claims |
|---|---|---|---|---|---|
| Top 20 Totals | 1,101,298 | $96,736,306 | |||
| Percent of Top 20 Drugs to Total EPIC Payments | 11.38% | 29.00% | |||
| 1 | PLAVIX (75 MG) | SS | 181,987 | $16,461,902 | 1 |
| 2 | NEXIUM (40 MG) | SS | 100,355 | $10,870,410 | 6 |
| 3 | ARICEPT (10 MG) | SS | 59,436 | $6,412,966 | 21 |
| 4 | SPIRIVA (18MCG) | SS | 81,414 | $6,293,418 | 14 |
| 5 | LIPITOR (20 MG) | SS | 74,356 | $5,891,217 | 16 |
| 6 | LIPITOR (10 MG) | SS | 86,309 | $4,838,255 | 11 |
| 7 | ADVAIR DISKUS (250-50MCG) | SS | 57,983 | $4,480,157 | 23 |
| 8 | PANTOPRAZOLE SODIUM (40 MG) | Gen | 55,547 | $4,251,729 | 24 |
| 9 | LIPITOR (40 MG) | SS | 47,732 | $3,968,281 | 32 |
| 10 | JANUVIA (100 MG) | SS | 32,103 | $3,574,420 | 56 |
| 11 | ACIPHEX (20 MG) | SS | 18,484 | $3,539,003 | 131 |
| 12 | NAMENDA (10 MG) | SS | 44,881 | $3,524,019 | 37 |
| 13 | ZETIA (10 MG) | SS | 44,273 | $3,237,831 | 38 |
| 14 | FLOMAX (0.4 MG) | BNMS | 40,403 | $3,094,921 | 40 |
| 15 | SINGULAIR (10 MG) | SS | 45,739 | $2,972,922 | 34 |
| 16 | LIDODERM (5%(700MG)) | SS | 26,187 | $2,764,546 | 79 |
| 17 | ACTOS (30 MG) | SS | 21,453 | $2,730,091 | 107 |
| 18 | ARIMIDEX (1 MG) | BNMS | 12,849 | $2,703,007 | 193 |
| 19 | CELEBREX (200 MG) | SS | 33,794 | $2,634,420 | 55 |
| 20 | CRESTOR (10 MG) | SS | 36,013 | $2,492,791 | 47 |
* Table IX lists the top 20 drugs ranked on EPIC Payments of adjudicated claims for the program year (October 2009-September 2010) as well as the percentage of the EPIC Payments they represent for the year.
** Drug Type values are BNMS='Brand Name Multi-Source', Gen='Generic' and SS='Sole Source.'
